Horizon (HZNP) Gets Positive CHMP Opinion for Uplizna in NMOSD

The CHMP gives a positive opinion on, and recommends approval to Horizon’s (HZNP) Uplizna for treating adult patients with neuromyelitis optica spectrum disorder.

Leave a comment

Your email address will not be published. Required fields are marked *